Concepedia

Michael Millward

MM

38

Publications

6.8K

Citations

28

H-Index

1996

Active since

Affiliations

The University of Western Australia(Current)

Sir Charles Gairdner Hospital

Peter MacCallum Cancer Centre

Russian Cancer Research Center NN Blokhin

Istituto Oncologico Veneto

Michael Millward is an author at The University of Western Australia specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1996–2020

38

Publications

38

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Axel Hauschild, Jean‐Jacques Grob, Lev Demidov et al. · The Lancet · 2012 · 2.9K citations

, , +6

Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group

Frank V. Fossella, Jose R. Pereira, Joachim von Pawel et al. · Journal of Clinical Oncology · 2003 · 942 citations

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

Agop Y. Bedikian, Michael Millward, Hubert Pehamberger et al. · Journal of Clinical Oncology · 2006 · 596 citations

Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Anthony T.�C. Chan, Mow-Ming Hsu, Boon Cher Goh et al. · Journal of Clinical Oncology · 2005 · 289 citations · Full text

Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and Paclitaxel

Jeremy Shapiro, Michael Millward, Danny Rischin et al. · Gynecologic Oncology · 1996 · 256 citations

, , +7

Rows per page

1–5 of 38